An engineered serum albumin-binding AAV9 capsid achieves improved liver transduction after intravenous delivery in mice

Gene Therapy, Published online: 09 December 2019; doi:10.1038/s41434-019-0107-2An engineered serum albumin-binding AAV9 capsid achieves improved liver transduction after intravenous delivery in mice

Source: Gene Therapy - December 8, 2019 Category: Genetics & Stem Cells Authors: Quan Jin Chunping Qiao Jianbin Li Juan Li Xiao Xiao Source Type: research